1975 - Lead role in the ethical and regulatory debates on recombinant DNA techniques
Medical Ethics
About This Innovation
* Singer was lead in new field of recombinant DNA technology, among the 1st to call attention to the possible risks of genetic engineering. * She organized the 1975 Asilomar conference in order to bring together scientists to impose restrictions and draw guidelines on recombinant DNA research, * Advocated for resumption of research under cautious safeguards until more was known about the potential biohazards of recombinant DNA technology.
Key Information
Category:
Medical Ethics
Completion Status:
done
Patent Number:
N/A
Patent Information
Patent Number: N/A
Technical Specifications
N/A
